carmustine; 154-93-8; 1,3-Bis(2-chloroethyl)-1-nitrosourea; BCNU; Carmustin; Gliadel; Nitrumon; Carmubris; BiCNU; Bi CNU; Carmustinum; Bischloroethyl nitrosourea; Bischlorethylnitrosurea; N,N'-BIS(2-CHLOROETHYL)-N-NITROSOUREA; Bischlorethylnitrosourea; Carmustina; Urea, N,N'-bis(2-chloroethyl)-N-nitroso-; 1,3-Bis(2-chloroethyl)nitrosourea; Bis(2-chloroethyl)nitrosourea; NSC-409962; FDA 0345; SRI 1720; BiCNU (TN); DTI 015; NCI-C04773; SK 27702; Bis(chloroethyl)nitrosourea; NSC 409962; UNII-U68WG3173Y; Carmustine (98%); NSC409962; CHEMBL513; 1,3-bis(2-chloroethyl)-1-nitroso-urea; CHEBI:3423; Urea, 1,3-bis(2-chloroethyl)-1-nitroso-; Becenum; Becenun; U68WG3173Y; MFCD00057706; 1,3-bis(2-chloroethyl)-3-nitrosourea; NCGC00015204-05; 1,3-Bis(.beta.-chloroethyl)-1-nitrosourea; Gliadel Wafer; Bischloroethylnitrosourea; DSSTox_CID_2743; DSSTox_RID_76712; Carmustinum [INN-Latin]; DSSTox_GSID_22743; Carmustina [INN-Spanish]; Bis(2-chloroethyl)1-nitrosourea; Bis-N,N'-(chloroethyl)nitrosourea; C5H9Cl2N3O2; CAS-154-93-8; CCRIS 810; 1,3-Bis(beta-chloroethyl)-1-nitrosourea; BCNU [Chloroethyl nitrosoureas]; SR-01000075736; EINECS 205-838-2; BRN 2049744; Carustine; AI3-52216; HSDB 7761; BiCNU; Nitrumon; Carmustine [USAN:USP:INN:BAN]; Prestwick_997; Gliadel (TN); Bischloroethyl nitrosourea [Chloroethyl nitrosoureas]; Carmustine(BiCNU)/; Gliadel (MGI Pharm); Spectrum_000265; Carmustine, >=98%; Spectrum4_000888; Spectrum5_000920; Lopac-C-0400; WLN: ONN2GVM2G; C 0400; SCHEMBL4503; Lopac0_000188; Carmustine (JAN/USP/INN); KBioGR_001296; KBioSS_000745; MLS001333962; DivK1c_000835; AMY382; GTPL6800; DTXSID8022743; HMS502J17; KBio1_000835; KBio2_000745; KBio2_003313; KBio2_005881; AOB6824; DTI-015; NINDS_000835; HMS2092J22; HMS2230I05; HMS3260F17; HMS3369D17; Pharmakon1600-01503110; BCP27690; FDA-0345; SRI-1720; ZINC3830387; Tox21_110097; Tox21_500188; ABP000292; ANW-61236; BDBM50015950; CCG-39925; NSC758392; STK624770; AKOS005558013; Tox21_110097_1; BCP9000490; DB00262; LP00188; MCULE-3131772074; NSC-758392; SDCCGSBI-0050176.P004; IDI1_000835; Urea,3-bis(2-chloroethyl)-1-nitroso-; NCGC00015204-01; NCGC00015204-02; NCGC00015204-03; NCGC00015204-04; NCGC00015204-06; NCGC00015204-07; NCGC00015204-08; NCGC00015204-09; NCGC00015204-18; NCGC00093665-01; NCGC00093665-02; NCGC00093665-03; NCGC00093665-04; NCGC00260873-01; Urea,N'-bis(2-chloroethyl)-N-nitroso-; AC-24196; AK-51731; AS-12106; HY-13585; N,N''-Bis(2-chloroethyl)-N-nitrosourea; NCI60_003931; SK-27702; SMR000058426; SBI-0050176.P003; AB0011283; EU-0100188; FT-0602937; S3669; BCNU; 1,3-Bis(2-chloroethyl)-1-nitrosourea; C06873; D00254; 13167-EP2270014A1; 13167-EP2272827A1; 13167-EP2272832A1; 13167-EP2275420A1; 13167-EP2277876A1; 13167-EP2292614A1; 13167-EP2295055A2; 13167-EP2295416A2; 13167-EP2295426A1; 13167-EP2295427A1; 13167-EP2298748A2; 13167-EP2298764A1; 13167-EP2298765A1; 13167-EP2298768A1; 13167-EP2298778A1; 13167-EP2305642A2; 13167-EP2308861A1; 13167-EP2311453A1; 13167-EP2311808A1; 13167-EP2311825A1; 13167-EP2311829A1; 13167-EP2311842A2; 13167-EP2314590A1; 13167-EP2316832A1; 13167-EP2316833A1; 13167-EP2316834A1; 13167-EP2374454A1; 15164-EP2272827A1; 15164-EP2316832A1; 15164-EP2316833A1; AB00052431-07; AB00052431_08; 154C938; A809590; Q415869; SR-01000075736-1; SR-01000075736-3; W-108025; Z1563145982; Carmustine, United States Pharmacopeia (USP) Reference Standard; 1-(2-Chloroethyl)-1-([(2-chloroethyl)amino]carbonyl)-2-oxohydrazine #